Selective suppression of nuclear retinoic acid receptor β gene expression in human pancreatic carcinomas

International Journal of Oncology

Volumn 8, Issue 3, 1996, Pages 445-451

  Xu, Xiao Chun ^a   Stier, Ute ^b   Rosewicz, Stefan ^b   El Naggar, Adel K ^a   Lotan, Reuben ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Nuclear retinoid receptors; Pancreatic cancer; Retinoids

Indexed keywords

RETINOIC ACID RECEPTOR;

ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; PANCREAS CARCINOMA; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0029897917     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Warshaw AL and Fernández-Del Castillo C: Pancreatic carcinoma. N Engl J Med 326: 455-465, 1992.
2. Wingo PA, Tong T and Bohlen S: Cancer statistics. CA Cancer J Clin 45: 8-30, 1995.
3. Williamson RCN: Pancreatic cancer: the greatest oncologic challenge. Br Med J 296: 445-446, 1991.
4. Bakkevold KE and Kambestad B: Long-term survival following radical and palliative treatment of patients with carcinoma of the pancreas and papilla of Vater: the prognostic factors influencing the long-term results. Eur J Surg Oncol 19: 147-161, 1993.
5. Lotan R, Francis GE, Freeman CS and Waxman S: Differentiation therapy. Cancer Res 50: 3453-3464, 1990.
6. Gudas LJ, Sporn MB and Roberts AB: Cellular biology and biochemistry of the retinoids: In: The Retinoids. Sporn MB, Roberts AB and Goodman DS (eds). Raven Press, New York pp443-520, 1994.
7. Smith MA, Parkinson DR, Cheson BD and Friedman MA: Retinoids in cancer therapy. J Clin Oncol 10: 839-864, 1992.
8. Hong WK and Itri LM: Retinoids and human cancer. In: The Retinoids. Sporn MB, Roberts AB and Goodman DS (eds). Raven Press, New York, pp 597-658, 1994.
9. Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, Fofonoff S, Byers R, Atkinson EN, Vaughan C, Toth BB, Kramer A, Dimery IW, Skipper P and Strong S: 13-cis retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315: 1501-1505, 1986.
10. Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SS, Kramer AM, Lotan R, Peters LL, Dimery IW, Brown BW and Goepfert H: Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 323: 795-801, 1990.
11. Chiesa F, Tradati N, Marazza M, Rossi N, Boracchi P, Mariani L, Clerici M, Formelli F, Barzan L, Carrassi A, Pastorini A, Cameriini T, Giardini R, Zurrida S, Minn FL, Costa A, De Palo G and Veronesi U: Prevention of local relapses and new localisations of oral leukoplakia with the synthetic retinoid fenretinide (4-HPR). Preliminary results. Oral Oncol Eur J Cancer 28B: 97-102, 1992.
12. Pastorino U, Infante M, Maioli M, Chiesa G, Buyse M, Pirket P, Rosementz N, Clerici M, Soresi E, Valente M, Belloni PA and Ravasi G: Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 11: 1216-1222, 1993.
13. Kraemer KH, DiGiovanna JJ, Moshell AN, Tarone RE and Peck GL: Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 318: 1633-1637, 1988.
14. Meyskens FL, Surwit E, Moon TE, Childers JM, Davis JR, Dorr RT, Johnson CS and Alberts DS: Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J Natl Cancer Inst 86: 539-543, 1994.
15. Huang M, Ye Y, Chen S, Chai J, Lu J, Zhoa L, Gu L and Wang Z: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72: 567-572, 1988.
16. Cheng A-L, Su I-J, Chen C-C, Tien H-F, Lay J-D, Chen B-R, Pu Y-S, Hong R-L, Shen M-C, Wang C-H and Chen Y-C: Use of retinoic acids in the treatment of peripheral T-cell lymphoma: a pilot study. J Clin Oncol 12: 1185-1192, 1994.
17. Frazier ML, Lilly BJ, Wu EF, Ota T and Hewett-Emmet D: Carbonic anhydrase II gene expression in cell lines from human pancreatic adenocarcinoma. Pancreas 5: 507-514, 1990.
18. Rosewicz S, Stier U, Brembeck F, Kaiser A, Berdel W, Wiedenmann B and Riecken EO: Retinoids: effects on growth, differentiation and nuclear receptor expression in human pancreatic carcinoma cell lines. Gastroenterology 109: 1646-1660, 1995.
19. Mangelsdorf DJ, Umesono K and Evans RM: The retinoid receptors. In: The Retinoids. Sporn MB, Roberts AB and Goodman DS (eds). Raven Press, New York, pp319-349, 1994.
20. Chambon P: The retinoid signalling pathway: molecular and genetic analyses. Sem Cell Biol 5: 115-125, 1994.
21. Pfahl M: Vertebrate receptors: molecular biology, dimerization and response elements. Sem Cell Biol 5: 95-103, 1994.
22. Mattei MG, Riviere M, Krust A, Ingvarsson S, Vennstrom B, Islam MQ, Levan G, Kastner P, Zelent A, Chambon P, Szpirer J and Szpirer C: Chromosomal assignment of retinoic acid receptor (RAR) genes in the human, mouse, and rat genomes. Genomics 10: 1061-1069, 1991.
23. Lehman JM, Dawson MI, Hobbs PD, Husmann M and Pfahl M: Identification of retinoids with nuclear receptor subtype-selective activities. Cancer Res 51: 4804-4809, 1991.
24. Morriss-Kay G: Retinoic acid receptors in normal growth and development. Cancer Surv 14: 181-193, 1992.
25. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM and Thaller C: 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68: 397-406, 1992.
26. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski T, Haselton C, Allenby G, Speck J, Kratzeisen C, Rosenberger M, Lovey A and Grippo JF: 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature 355: 359-361, 1992.
27. Xu X-C, Clifford JL, Hong WK and Lotan R: Detection of nuclear retinoic acid receptor mRNA in histological tissue sections using nonradioactive in situ hybridization histochemistry. Diag Mol Pathol 3: 122-131, 1994.
28. Petkovich M, Brand NJ, Krust A and Chambon P: A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330: 444-450, 1987.
29. Brand N, Petkovitch M, Krust A, Chambon P, de The H, Marchio A, Tiollais P and Dejean A: Identification of a second human retinoic acid receptor. Nature 332: 850-853, 1988.
30. Krust A, Kastner P, Petkovich M, Zelent A and Chambon P: A third human retinoic acid receptor, hRAR-γ. Proc Natl Acad Sci USA 86: 5310-5314, 1989.
31. Mangelsdorf DJ, Ong ES, Dyck JA and Evans RM: Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345: 224-229, 1990.
32. Kissane JM: Tumors of the exocrine pancreas: pathological aspects. J Surg Oncol 7: 167-174, 1975.
33. Griffin CA, Hruban RH, Long PP, Morsberger LA, Douna-Issa F and Yeo CJ: Chromosome abnormalities in pancreatic adenocarcinoma. Genes Chromosom Cancer 9: 93-100, 1994.
34. Houle B, Rochette-Egly C and Bradley WE: Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells. Proc Natl Acad Sci USA 90: 985-989, 1993.
35. Xu X-C, Ro JY, Lee JS, Shin DM, Hong WK and Lotan R: Differential expression of nuclear retinoic acid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res 54: 3580-3587, 1994.
36. Gebert JF, Moghal N, Frangioni JV, Sugarbaker DJ and Neel BG: High frequency of retinoic acid receptor beta abnormalities in human lung cancer. Oncogene 6: 1859-1868, 1991.
37. Houle B, Leduc F and Bradley WE: Implication of RARβ in epidermoid (squamous) lung cancer. Genes Chromosomes Cancer 3: 358-366, 1991.
38. Nervi C, Vollberg TM, George MD, Chambon P and Jetten AM: Expression of nuclear retinoic acid receptors in normal tracheobronchial cells and in lung carcinoma cells. Exp Cell Res 195: 163-170, 1991.
39. Geradts J, Chen J-Y, Russell EK, Yankaskas JR, Nieves L and Minna JD: Human lung cancer cell lines exhibit resistance to retinoic acid treatment. Cell Growth Differ 4: 799-809, 1993.
40. Lotan R, Xu X-C, Lippman SM, Ro JY, Lee JS, Lee JJ and Hong WK: Suppression of retinoic acid receptor-β in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med 332: 1405-1410, 1995.
41. De The H, Vivanco-Ruiz MDM, Tiollais P, Stunnenberg H and Dejean A: Identification of a retinoic acid responsive element in the retinoic acid receptor β gene. Nature 343: 177-180, 1990.
42. Sucov HM, Murakami KK and Evans RM: Characterization of an autoregulated response element in the mouse retinoic acid receptor type β gene. Proc Natl Acad Sci USA 87: 5392-5396, 1990.
43. Hoffmann B, Lehmann JM, Zhang XK, Hermann T, Husmann M, Graupner G and Pfahl M: A retinoic acid receptor-specific element controls the retinoic acid receptor-beta promoter. Mol Endocrinol 4: 1727-1736, 1990.
44. Zhang X-K, Liu Y and Pfahl M: A specific defect in the retinoic acid response associated with human lung cancer cell lines. Cancer Res 54: 5663-5669, 1994.
45. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N and Perucho M: Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53: 549-554, 1988.
46. Hruban RH, van Mansfeld ADM, Offerhaus GJA, van Weering DHJ, Allison DC, Goodman SN, Kensler TW, Dose KK, Cameron JL and Bos JL: K-ras oncogene activation in adenocarcinoma of the human pancreas. Am J Pathol 143: 545-554, 1993.
47. Yanagisawa A, Ohtake K, Ohashi K, Hori M, Kitagawa T, Sugano H and Kato Y: Frequent c-K-ras oncogene activation in mucous cell hyperplasia of pancreas suffering from chronic inflammation. Cancer Res 53: 953-956, 1993.
48. Lemoine NR, Jain S, Hughes C, Staddon SL, Maillet B, Hall PA and Klöppel G: Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology 102: 230-236, 1992.
49. Yamada H, Sakamoto H, Taira M, Nishimura S, Shimosato Y, Terada M and Sugimura T: Amplification of both c-Ki-ras with a point mutation and c-myc in a primary pancreatic cancer and its metastatic tumors in lymph nodes. Jpn J Cancer Res 7: 370-375, 1986.
50. Horii A, Nakaturu S, Miyoshi Y, Ichii S, Nagase H, Ando H, Yanagisawa A, Tsuchiya E, Kato Y and Nakamura Y: Frequent somatic mutations of the APC gene in human pancreatic cancer. Cancer Res 52: 696-698, 1992.
51. DiGuiseppe JA, Hruban RH, Goodman SN, Allison DA, Cameron JL and Offerhaus JGA: Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol 101: 684-688, 1994.
52. Redston MS, Caldas C, Seymour AB, Hruban RH, da Costa L, Yeo CJ and Kern SE: p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res 54: 3025-3033, 1994.
53. Ruggeri B, Zhang S-Y, Caamano J, DiRado M, Flynn SD and Klein-Szanto AJP: Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes. Oncogene 7: 1503-1511, 1995.